Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Breast Cancer Patients at Risk for Recurrence After Surgical and Medical Therapies

NCT00841399 is registered in ClinicalTrials.gov with COL George Peoples, MD, FACS as lead sponsor.

NCT NCT00841399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Breast Cancer Patients at Risk for Recurrence After Surgical and Medical Therapies
Lead sponsor
COL George Peoples, MD, FACS
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2001
Completion date
March 31, 2013
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer